The University of Pennsylvania Health System has received final approval to move forward with its merger with Doylestown Health, writes Ryan Mulligan for the Philadelphia Business Journal.
In January, Penn Medicine and Doylestown Health announced that they had signed a letter of intent to pursue a merger. With the final approval now granted, Penn Medicine will integrate the 247-bed Bucks County hospital into its system as it proceeds to expand in Philadelphia’s suburbs.
According to Penn Medicine CEO Kevin Mahoney and COO Michele Volpe, the deal will be officially marked at Doylestown Hospital on April 1.
“This is an important step in our health system’s growth and transformation, especially as we continue to reimagine the ways and places in which we can deliver exceptional care to more patients in the Philadelphia suburbs,” they said.
In the first half of its 2025 fiscal year, Doylestown Health reported $13.7 million in operating losses, up from $8.1 million in the same period a year earlier. In fiscal 2024, the hospital posted $466.8 million in revenue which was a 12 percent increase from $417.9 million in fiscal 2023.
Read more about the Penn Medicine and Doylestown Health merger and what it means for the region’s health in the Philadelphia Business Journal.
_____
